Back to Search
Start Over
Ineffective treatment of PML with pembrolizumab: Exhausted memory T-cell subsets as a clue?
- Source :
- Neurology® Neuroimmunology & Neuroinflammation
- Publication Year :
- 2019
-
Abstract
- Progressive multifocal leukoencephalopathy (PML) is a rare pathologic CNS condition caused by JC polyomavirus (JCPyV) in immunodeficient patients. Immune checkpoint inhibition was previously reported to potentially facilitate the antiviral response.1
- Subjects :
- Adult
Male
viruses
Pembrolizumab
Antibodies, Monoclonal, Humanized
Leukoencephalopathy
03 medical and health sciences
0302 clinical medicine
T-Lymphocyte Subsets
medicine
Humans
Immunologic Factors
030212 general & internal medicine
Clinical/Scientific Notes
biology
business.industry
Progressive multifocal leukoencephalopathy
Leukoencephalopathy, Progressive Multifocal
virus diseases
biochemical phenomena, metabolism, and nutrition
medicine.disease
Immune checkpoint
medicine.anatomical_structure
Editorial
Neurology
Immunology
Monoclonal
biology.protein
Neurology (clinical)
Antibody
business
Memory T cell
Immunologic memory
Immunologic Memory
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 23327812
- Volume :
- 6
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- Neurology(R) neuroimmunologyneuroinflammation
- Accession number :
- edsair.doi.dedup.....8bc48838b0bd150ba8f56ba56cc19713